# Sanofi: Form 13F holdings

An institutional investment manager in Paris. SEC CIK 1121404.

- Quarter ended: 2026-06-30
- Filed: 2026-07-28
- Reported value: $534.0m
- Positions: 10 (10 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1121404/000119312526318812/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| MeiraGTx Holdings plc | COM | $164.8m | 30.9% | 12,197,737 |  | Unchanged |
| [Inhibrx Biosciences, Inc. (INBX)](/companies/inbx.md) | COM | $109.7m | 20.5% | 1,157,926 |  | Unchanged |
| [Novavax (NVAX)](/companies/nvax.md) | COM NEW | $64.8m | 12.1% | 6,880,481 |  | Unchanged |
| [AnaptysBio (ANAB)](/companies/anab.md) | COM | $55.5m | 10.4% | 821,917 |  | Unchanged |
| [Odyssey Therapeutics Inc. (ODTX)](/companies/odtx.md) | COMMON STOCK | $37.3m | 7.0% | 1,991,918 |  | New +1,991,918 |
| [Agomab Therapeutics NV (AGMB)](/companies/agmb.md) | SPONSORED ADS | $36.1m | 6.8% | 2,783,096 |  | Unchanged |
| [MapLight Therapeutics Inc. (MPLT)](/companies/mplt.md) | COM | $32.7m | 6.1% | 912,041 |  | Unchanged |
| [First Tracks Biotherapeutics Inc. (TRAX)](/companies/trax.md) | ORD SHS | $16.5m | 3.1% | 821,917 |  | New +821,917 |
| [Immuneering Corp (IMRX)](/companies/imrx.md) | CLASS A COM | $13.5m | 2.5% | 2,708,559 |  | Unchanged |
| [Q32 Bio Inc. (QTTB)](/companies/qttb.md) | COM | $3.1m | 0.6% | 244,083 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [Eledon (ELDN)](/companies/eldn.md) | COM | $0 | 0.0% | 0 |  | Sold out −814,980 |

Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-318812. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.